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Abstract 
Background. A growing literature supports the role of immune system alterations in the 
etiology of mood regulation, yet there is little population-based evidence regarding the 
association between persistent pathogens, inflammation and mood disorders among 
younger women and men in the U.S. Methods. We used data from the National Health 
and Nutrition Examination Survey III on individuals 15-39 years of age assessed for 
major depression, dysthymia, and/or bipolar disorder I and tested for cytomegalovirus 
(N=6825), herpes simplex virus (HSV)-1 (N=5618) and/or Helicobacter pylori (H. pylori) 
(N=3167) seropositivity as well as C-reactive protein (CRP) level (N=6788). CMV 
immunoglobulin G (IgG) antibody level was also available for a subset of women 
(N=3358). We utilized logistic regression to estimate the odds ratio (OR) and 95% 
confidence interval (CI) for the association between pathogens, CRP levels and each 
mood disorder overall and among women and men, separately.  Results. H. 
pylori seropositivity was associated with increased odds of dysthymia (OR 2.37, 95% 
confidence interval (CI): 1.07, 5.24) among women, but decreased odds among men 
(OR 0.51, 95% CI: 0.28, 0.92). CMV seropositivity was also associated with lower odds 
of depression (OR 0.54, 95% CI: 0.32, 0.91) among men, while elevated CMV IgG level 
was marginally associated with increased odds of mood disorders among women. 
Associations were not mediated by CRP level. Conclusions. Our findings suggest that 
persistent pathogens such as CMV and H. pylori may differentially influence mood 
disorders among women and men, warranting further investigation into biological and/or 
sociocultural explanations for the contrasting associations observed. 
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1. Introduction 
More than 20% of U.S. adults between the ages of 18-49 have experienced a 
mood disorder such as major depressive disorder, dysthymia, or bipolar disorder in their 
lifetime (Kessler et al., 2005).  Individuals who experience mood disorders are more 
likely to engage in substance abuse (Regier et al., 1990), have other co-morbid medical 
conditions (Forty et al., 2014; Kang et al., 2015) and experience poorer psychosocial 
functioning across the life course (Coryell et al., 1993; Mehta et al., 2014; Rhebergen et 
al., 2010), with depression predicted to be the leading cause of disability worldwide by 
2030 (Mathers, 2008). While much research has focused on identifying genetic and 
behavioral risk factors for the onset of mood disorders (Hirschfeld, 2002), the role that 
interactions between the immune system and the brain may play in mood regulation, 
has been increasingly recognized (Dantzer et al., 2008; Dantzer et al., 2011; Hamdani 
et al., 2013; Muneer, 2016). It is now well-understood, for example, that inflammation 
plays a key role in inducing symptoms commonly referred to as “sickness behavior” that 
overlap with those of depression (Dantzer et al., 2008; McCusker and Kelley, 2013) and 
in regulation of glutamatergic neurotransmission important for regulation of mood in 
both depression and bipolar disorder (Dantzer et al., 2011; Machado-Vieira et al., 2012) 
(Barbosa et al., 2014).  Specifically, microglia in the brain are activated by inflammatory 
cytokines that cross the blood-brain barrier, altering astroglial function such that these 
cells produce increased levels of cytokines as well as glutamate, contributing to 
enhanced tryptophan metabolism via the indoleamine 2,3-dioxygenase pathway 
(Barbosa et al., 2014; Dantzer et al., 2011; Machado-Vieira et al., 2012). Imbalances in 
the metabolites of kynurenine which serve as either N-methyl-D-aspartate agonists or 
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antagonists and decreased serotonin production, in turn, may contribute to the onset of 
manic and depressive symptoms (Barbosa et al., 2014; Dantzer et al., 2011; Machado-
Vieira et al., 2012). Microglial activation in the brain may also contribute to neural 
damage implicated in the etiology of depression and bipolar disorder (Muneer, 2016; 
Valkanova et al., 2013).  
While acute infections may induce short-term increases in inflammation, 
researchers have hypothesized that persistent pathogens such as herpesviruses may 
serve as particularly salient infections in the etiology of mood disorders (Miller et al., 
2005; Phillips et al., 2008; Prossin et al., 2015; Rector et al., 2014; Simanek et al., 2014; 
Trzonkowski et al., 2004). Once acquired, such pathogens are never cleared from the 
body and consequently may repeatedly stimulate the immune system over time, during 
periods of reactivation (Glaser R, 1994). Existing studies examining the association 
between herpesviruses including cytomegalovirus (CMV) and herpes simplex virus 
(HSV)-1 and outcomes such as depression and bipolar disorder have however, been 
primarily been conducted among older populations from specific geographic regions 
(Miller et al., 2005; Phillips et al., 2008; Prossin et al., 2015; Rector et al., 2014; 
Simanek et al., 2014; Trzonkowski et al., 2004) and findings regarding the mediating 
role of inflammation in the pathway between such pathogens have been mixed (Miller et 
al., 2005; Rector et al., 2014; Simanek et al., 2014; Trzonkowski et al., 2004). 
Helicobacter pylori (H. pylori), a gram-negative bacteria that can lead to persistent 
infection of the gut is another pathogen thought to chronically activate the immune 
system (Di Leo et al., 2005; Robinson et al., 2007). This pathogen has been linked to 
several gastrointestinal disorders with inflammation-related etiology (Ruggiero, 2010) 
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and a growing body of evidence also supports the role of interactions at the “gut-brain” 
axis in regulation of mood (Budzyński and Kłopocka, 2014; Deans, 2017; Evrensel and 
Ceylan, 2015). To our knowledge there are no studies, however, examining the 
association between H. pylori and mood disorders such as depression or bipolar 
disorder. Overall, there is a need to clarify whether persistent pathogens such as 
herpesviruses and H. pylori are associated with mood disorders in the younger, U.S. 
adult population and further examine the potential role of inflammation in mediating 
these associations. 
Gender differences in prevalence and/or severity of mood disorders such as 
depression and bipolar disorder have also been well-documented (Diflorio and Jones, 
2010; Piccinelli and Wilkinson, 2000) and increased incidence of conditions with 
inflammation-related etiology among women has recently been posited to explain this 
pattern (Derry et al., 2015; Diflorio and Jones, 2010; Piccinelli and Wilkinson, 2000). 
Women are more likely to be seropositive for and to have poorer cell-mediated immune 
control of herpesviruses (Dowd and Aiello, 2009; Dowd et al., 2009; Schillinger et al., 
2004; Staras et al., 2006), which some studies have linked to elevated systemic 
inflammation (Bennett et al., 2012; Nazmi et al., 2010; Turner et al., 2014). While 
seroprevalence of H. pylori has been reported to be higher in men than women 
(Everhart et al., 2000), recent studies have identified differences in the composition of 
the gut microbiome between men and women which could serve to moderate the 
pathogenicity of H. Pylori (Dominianni et al., 2015; Haro et al., 2016). For example, 
Haro et al., identified higher levels of Veillonella and Methanobrevibacter genera in the 
gut microbiome of men compared to women, whereas levels of Bacteroides and 
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Bilophila was higher in women (Haro et al., 2016). Bilophila wadsworthia has been 
shown in animal models to promote Th1-dominated immune response (Devkota et al., 
2012) and researchers have hypothesized that differential abundance of Th-promoting 
or inhibiting microbes could influence the host’s inflammatory response to H. pylori 
infection (Rolig et al., 2013). Taken together, this suggests that the role of persistent 
pathogens in the etiology of mood disorders may differ for women compared to men. 
This study utilizes data from a US national representative sample of young- to 
middle-aged adults to 1) examine the association between CMV, HSV-1 and H. pylori 
seropositivity as well as CMV immunoglobulin G (IgG) antibody levels (available among 
women only) and lifetime history of mood disorder outcomes including major 
depression, dysthymia and bipolar disorder I, 2) examine the mediating role of 
inflammation in these associations, and 3) assess whether these associations differ 
between women and men. 
2. Materials and Methods 
2.1. Study Population 
Data come from the National Health and Nutrition Examination Survey 
(NHANES) III (1988–1994); a population-based, multistage stratified probability survey 
which collects information on the health and nutrition of the United States, civilian, non-
institutionalized population. The survey was carried out by the National Center for 
Health Statistics (NCHS), Centers for Disease Control and Prevention, from 1988 to 
1994 and is designed to be representative of the US population. All participants in 
NHANES III provided informed consent at the time of enrollment. Only individuals 15-39 
years of age were assessed for lifetime history of one or more mood disorders including 
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major depression, dysthymia and bipolar disorder I and II via the Diagnostic Interview 
Schedule, a structured psychiatric interview that employs DSM-III criteria (N=8449). Our 
sample was further limited to those that were also tested for seropositivity for CMV 
(N=6825), HSV-1 (N=5618) and/or H. pylori (N=3167) seropositivity as well as C-
reactive protein (CRP) level (N=6792) and missing no data on covariates of interest. In 
addition, CMV immunoglobulin G (IgG) optical density (OD) values were available for 
3358 women tested for CMV seropositivity. Individuals categorized as “Other” 
race/ethnicity were excluded due to limited sample size for this subgroup. 
2.2. Laboratory Analyses 
CMV specific IgG was measured by a commercially available Enzyme Linked 
Immunosorbent Assay (ELISA) (Quest International, Inc., Miami, FL). Sera with values 
near the ELISA cutoff were confirmed with a second ELISA assay (bioMerieux, Inc., 
Durham, NC). If the results from the first two tests disagreed, an Immunofluorescence 
Assay (IFA) (Bion International, Inc., Park Ridge, IL), was used and results from this test 
were provided as the final seropositivity test result. The sensitivity and specificity of 
these tests have been estimated to be 98 and 99%, respectively (Staras et al., 
2006). Optical density (OD) values from the first ELISA test were available for a subset 
of women tested for CMV seropositivity (N=3435). OD values ≥ 3.0 were top-coded and 
women tested for CMV were categorized as having high (i.e., ≥ 3.0) or low (i.e., < 3.0) 
OD values. HSV-1 seropositivity was assessed by solid-phase enzymatic immunodot 
assays using purified glycoprotein gG-1 of HSV-1 as the antigen.(Schillinger et al., 
2004) These immunodot assays have also been shown to have high sensitivity and 
specificity (Lee et al., 1986). In individuals ages 6-19 years of age from phase 1 (1988–
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1991) of the study, IgG antibodies to H. pylori were measured via an enzyme-linked 
immunoassay (ELISA) (Pylori Stat, Whittaker Bioproducts, Walkersville, MD) in 1993 
and in individuals ≥ 20 years of age from phase 1 via a different ELISA in 1996 
(Wampole Laboratories, Cranbury, NJ) (Statistics., 2006).   
Sera collected for the purpose of CRP testing were stored at -70 C and analyzed 
within 2 months using a modification of the Behring Latex-Enhanced CRP assay on the 
Behring Nephelometer Analyzer system™ (Behring Diagnostics, Westwood, MA). Both 
within and between-assay quality control procedures were used and the coefficient of 
variation was 3.2%–16.1% through the period of data collection. The limit of detection 
for CRP was 0.3 mg/dL (Gunter, 1996) and individuals were categorized as having low 
(i.e., < 0.3 mg/DL) or high (≥ 0.3 mg/dL) levels. 
2.3. Outcomes 
 
During the physical examination, individuals 15-39 years of age were assessed 
as ever having met the criteria for several mood disorder diagnoses including major 
depression, dysthymia, bipolar disorder type I and atypical bipolar disorder (i.e., bipolar 
type II) via the Diagnostic Interview Schedule, a structured psychiatric interview based 
upon the Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (DSM-III) 
criteria (Association, 1980). Individuals were categorized as having a lifetime history or 
no history of each mood disorder outcome. 
2.4. Covariates 
Covariates hypothesized as potential confounders of the association between 
persistent pathogens and mood disorders included age at interview (years), 
race/ethnicity (Non-Hispanic white, Non-Hispanic black, or Mexican-American), gender 
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(male or female), poverty income ratio (PIR, ratio of family’s income to the federal 
poverty threshold per family size) (0-125%, >125-249%, >250%), smoking status 
(never; < 100 cigarettes in their lifetime, former; ≥ 100 cigarettes in their lifetime but did 
not smoke currently, or current smoker; ≥ 100 cigarettes in their lifetime and smoke 
currently, alcohol use (never drinker;<12 drinks in their lifetime or last 12 months, 
moderate drinker; >=12 drinks in last 12 months and <4 drinks per day for females or<5 
drinks per day for males, on days they drank, or heavy drinker; >=12 drinks in last 12 
months and ≥4 drinks per day for females or ≥5 drinks per day for males, on days they 
drank), body mass index (kg/m2), and prescription medication use in the past month 
including non-steroidal anti-inflammatory drugs (NSAIDS), infection-related medications 
(i.e., antimicrobials, antivirals, antifungals and/or other antibiotics); and/or mood 
disorder-related medications (i.e., anti-depressant, anti-anxiety and/or anti-psychotics) 
according to the National Drug Code Directory prepared by the Product Information 
Management Branch of the Food and Drug Administration (Statistics, 1998. ). Subjects 
who self-reported use of Advil, Nuprin, Medipren or Ibuprofen in the past month were 
also categorized as taking NSAIDS in the past month. 
2.5. Statistical Analyses 
Statistical analyses were performed using SAS v. 9.4 (SAS Institute Inc., USA). 
All analyses used appropriate weights and adjustments for strata and clustering to 
account for the complex survey design in NHANES III. We first estimated the weighted 
sociodemographic and behavioral characteristics of individuals assessed for mood 
disorder outcomes. We estimated the student’s t-test to examine difference in mean 
values for continuous variables and the Rao-Scott Chi-square test for difference in 
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proportions for categorical variables comparing women and men. Logistic regression 
was used to estimate the odds ratio (OR) and 95% confidence interval (CI) for the 
association between seropositivity for each pathogen as well as high CMV IgG antibody 
level (i.e., >3.0 optical density (OD) units) among CMV seropositive women (n=2307), 
and each outcome, adjusting for age, gender, race/ethnicity, PIR, BMI, smoking status, 
alcohol use, and use of infection-related or mood disorder-related medications. 
Individuals with missing data on any covariates of interest were excluded from all 
analyses. Logistic regression was also used to estimate the OR (95% CI) for the 
association between seropositivity for each pathogen as well as high CMV IgG antibody 
level among CMV seropositive women and CRP level, adjusting for age, gender, 
race/ethnicity, PIR, BMI, smoking status, alcohol use, and use of infection-related 
medications and/or NSAIDS. Last, we estimated the OR (95% CI) for the association 
between CRP level and each mood disorder outcomes in fully adjusted models in which 
medications controlled for included mood disorder-related medications and/or NSAIDS. 
Analyses were conducted for the full sample and stratified by gender. We also ran 
models including interaction terms between gender and pathogens (mood disorder and 
CRP level as outcome) or gender and inflammatory markers (mood disorders as 
outcome). Due to limited number of bipolar disorder II cases, we did not examine the 
association between exposures of interest and this outcome. 
3. Results 
Population-weighted sociodemographic and behavioral characteristics of 
individuals assessed for one or more mood disorders in the overall sample as well as 
among women and men, separately, are shown in Table 1. The mean (± SE) age of 
  
11 
 
individuals included in our sample was 27.6 (± 0.17), 51.9% were female, the majority 
were categorized as Non-Hispanic White (78.8%), and 20.5% had a PIR of <125%. The 
majority of individuals never smoked (53.3%), 19.4% were heavy drinkers and the mean 
(± SE) BMI of those included in our sample was 25.5 (± 0.13). Approximately 30% of 
individuals used NSAIDS in the past month, whereas 8.7% used infection-related 
medications and 1.6% used mood disorder-related drugs. Over half of individuals were 
HSV-1 seropositive (58.0%), whereas 46.5% and 23.0% of individuals were seropositive 
for CMV and H. pylori, respectively and 20.1% had elevated levels of CRP (≥ 0.3 
mg/dL). Over half of individuals were HSV-1 seropositive (53.4%), whereas 46.6% and 
23.0% of individuals were seropositive for CMV and H. pylori, respectively. 
Approximately 8.0% of individuals in our sample met the criteria for lifetime history of 
major depression, 6.0% for history of dysthymia and < 1% for history of bipolar disorder 
I. A greater proportion of men reported Mexican-American race/ethnicity, had a PIR 
>250%, were current smokers and reported heavy alcohol use, compared to women. In 
contrast, a greater proportion of women reported use of mood disorder-related and 
infection-related medications as well NSAIDS, were seropositive for CMV as well as 
HSV-1, had elevated CRP levels, lifetime history of major depression, and dysthymia, 
compared to men.  Sample characteristics were similar among subsets of individuals 
tested for each pathogen (data not shown). 
Table 2 shows the association between pathogens as well as CRP level and 
depression. There was no association between any pathogen and depression among 
the overall sample, nor among women, but there was a protective effect of CMV and H. 
pylori seropositivity on depression among men (OR 0.55, 95% CI: 0.33, 0.91 and OR 
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0.34, 95% CI: 0.2, 0.54, respectively, p-value for interaction = 0.0405 and 0.0037, 
respectively). Elevated CRP level was not associated with depression among the 
overall sample, nor among women, but among men, those with CRP level of ≥ 0.3 
mg/dL had 2.78 (95% CI: 1.41, 5.48) times higher odds of depression, compared to men 
with levels < 0.3 mg/dL in in fully adjusted models (p-value  for interaction = 0.0001). 
The association between pathogens as well as CRP level and dysthymia is 
shown in Table 3. While CMV, HSV-1 and H. pylori seropositivity were associated with 
dysthymia in the overall sample (OR 1.42, 95% CI 1.02, 1.97, OR 1.57, 95% CI: 1.16, 
2.12, and OR 1.85, 95% CI: 1.12, 3.07, respectively), these associations were 
attenuated and no longer statistically significant after covariate adjustment (see Table 
3). Elevated CMV IgG antibody level was positively associated with dysthymia among 
CMV seropositive women (OR 1.78, 95% CI: 1.18, 2.84), however, the effect was 
slightly attenuated and no longer statistically significant in the fully adjusted model (OR 
1.50, 95% CI: 0.93, 2.41). In analyses stratified by gender, H. pylori seropositivity was 
associated with dysthymia in the fully adjusted model (OR 2.47, 95% CI: 1.06, 5.73) 
among women, whereas H. pylori seropositivity was associated with a decreased odds 
of dysthymia among men (OR 0.51, 95% CI: 0.28, 0.92, p-value for interaction=0.0075). 
There was no statistically significant association between elevated CRP level and 
dysthymia among the overall sample or among women, but among men, the odds of 
dysthymia for those with elevated CRP level was 2.87 (95% CI: 1.56, 5.28) time higher 
compared to those with low CRP levels (p-value for interaction =0.0023). 
Table 4 shows the association between pathogens as well as CRP level and 
bipolar disorder I. There was no statistically significant association between CMV, HSV-
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1 or H. pylori seropositivity and bipolar disorder I among the overall sample, however, 
there was an association between this pathogen and bipolar disorder I in a protective 
direction among men (OR 0.24, 95% CI: 0.06, 0.91) in the fully adjusted model (p-value  
for interaction = 0.1156). While elevated CMV IgG antibody levels were also associated 
with bipolar disorder I among CMV seropositive women in the unadjusted model (OR 
4.92, 95% CI: 1.17, 20.83), this association was slightly attenuated and no longer 
statistically significant after covariate adjustment (OR 4.34, 95% CI: 0.92, 20.45, p-value 
= 0.0623). There was a positive relationship between elevated CRP level and bipolar 
disorder I among the overall sample as well as among women and men, separately, but 
these associations were also not statistically significant (see Table 4). 
The associations between each pathogen and elevated CRP level are illustrated 
in Figure 1. In crude models, CMV and HSV-1 seropositivity were associated with 
elevated CRP level in the overall sample (OR 1.40, 95% CI: 1.13, 1.74 and OR 1.32, 
95% CI: 1.11, 1.59, respectively) and for women (OR 1.29, 95% CI: 0.99, 1.69 and OR 
1.34, 95% CI: 1.07, 1.68, respectively), but these associations were attenuated and no 
longer statistically significant after covariate adjustment (see Figure 1). We 
consequently did not further assess the mediating role of CRP level in the associations 
between persistent pathogens and mood disorders. 
4. Discussion 
 To our knowledge, this is the first study to examine the association between 
several persistent pathogens and an array of mood disorder outcomes among a 
population-based sample of younger US adults. We found that H. pylori seropositivity 
was associated with 2.5 times higher odds of dysthymia among women. Among men, in 
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contrast, H. pylori seropositivity was associated with decreased odds of both depression 
and dysthymia. While men with high versus low CRP levels had higher odds of 
depression, there were no associations between any pathogens and CRP in our study. 
Our findings suggest there is a need for further investigation into the biological as well 
as sociocultural mechanisms driving differences in the association between persistent 
pathogens and mood disorders between women and men in the general U.S. adult 
population. 
We hypothesized that H. pylori may be involved in the etiology of mood disorders 
via inflammatory pathways, and that the inflammatory effects of this pathogen may differ 
for women compared to men. Our findings suggest however, that H. pylori may act 
outside of inflammatory pathways to differentially effect risk for mood disorders in 
women and men. As this is the first study, to our knowledge, to examine gender 
differences in the association between H. pylori and mood disorders, replication of our 
analyses in additional study populations as well as further investigation into drivers of 
the heterogeneous effects of H. pylori on mood disorders between women and men 
observed in our study are needed. Sex differences in the relationship between H. pylori 
and the orexigenic hormone, ghrelin (Chuang et al., 2009; Stec-Michalska et al., 2009), 
which is produced by endocrine cells in the gastrointestinal tract and has been linked in 
some studies to mood disorders (Zarouna et al., 2015) may serve as one explanation 
for our findings. For example, Chuang et al. recently demonstrated in a small cohort of 
dyspeptic patients (N=341), that H. pylori infection was associated with higher ghrelin 
levels among women (not statistically significant), but decreased levels among men 
(p=0.02) (Chuang et al., 2009). Some (Gecici et al., 2005; Ozsoy et al., 2014), although 
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not all (Zarouna et al., 2015), studies have identified higher levels of ghrelin in 
depressed individuals compared to those not depressed.  
The finding of no association between CMV and HSV-1 seropositivity and depression is 
consistent with results from previous studies conducted among cohorts of middle-aged 
adults (Amsterdam and Hernz, 1993; Rector et al., 2014; Simanek et al., 2014). For 
example, Simanek et al. found no association between CMV or HSV-1 seropositivity 
and depression in a community-based sample of middle-aged (mean age 54.0 ± 15.8 
years) Detroit residents (Simanek et al., 2014). Similarly, Rector et al. found no 
association between CMV seropositivity and depression among a cross-sectional 
sample of middle-aged (mean age 44) individuals in a German occupational cohort 
(Rector et al., 2014). The direction of the association between CMV IgG antibody level 
and mood disorder outcomes among women who were CMV seropositive, observed in 
our study was consistent, however, with findings from several previous studies 
examining this association with depression as well as bipolar disorder (Jaremka et al., 
2013; Miller et al., 2005; Phillips et al., 2008; Prossin et al., 2015; Rector et al., 2014; 
Simanek et al., 2014; Trzonkowski et al., 2004), but only marginally statistically 
significant. CMV has been hypothesized as a major driver of aging of the adaptive 
immune system (Derhovanessian et al., 2009). Indeed, a recent study demonstrated 
that higher CMV IgG antibody levels were associated with an increase in the ratio of 
effector to naïve CD4 and CD8 T cell subsets among middle-aged adults living in Detroit 
(Aiello et al., 2016). A growing body of literature suggests that T cell function may, in 
turn, play an important role in the etiology of mood disorders (Barbosa et al., 2014; 
Duggal et al., 2014; Miller, 2010; Toben and Baune, 2015).  It is possible that the 
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younger mean age of our study population may provide less variation in immune 
response to CMV compared to older populations, potentially dampening the association 
between CMV IgG antibody level and mood disorders among women in our study. 
 In contrast to our findings for women, we observed a statistically significant 
protective association between CMV seropositivity and mood disorders among men, 
suggesting that there may be gender differences in the effect of CMV on mood 
regulation between women and men. While CMV IgG antibody levels were only 
available for women in our sample and thus we could not assess whether there was 
variation in the effect of immune response to CMV on these outcomes between women 
and men, researchers have hypothesized that sex hormones (Dowd et al., 2013; van 
der Heiden et al., 2016; Zhu et al., 2000) and/or differential exposure to stress-mediated 
reactivation (Dowd and Aiello, 2009; Dowd et al., 2008) may play a key role in shaping 
differences in immune control of CMV between men and women. A recent study also 
suggests that the adverse effects of CMV on alterations to the T cell repertoire worsen 
for women over time (van der Heiden et al., 2016), warranting further investigation into 
whether variability in in the adverse effects of CMV infection on immune aging between 
women in men may partially explain the protective effect of CMV on mood disorders, 
observed among this population of younger men in our study is therefore warranted. 
Similar to Ford et al. (Ford and Erlinger, 2004), we observed a strong positive 
association between elevated CRP and depression among men, but there was no 
statistically significant associations between any pathogens and CRP levels in the 
overall sample, nor among women and men separately. Thus, elevated CRP level did 
not meet the criteria as a mediator of the associations of interest. Our findings are 
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similar to those from the study by Simanek et al. in which the authors did not identify an 
association between CMV or HSV-1 seropositivity or HSV-1 IgG antibody level and 
levels of the pro-inflammatory markers CRP or interleukin-6, nor find evidence that 
these pro-inflammatory markers mediated the association between CMV IgG antibody 
level and depression onset (Simanek et al., 2014). Another recent study demonstrated 
that women who were exposed experimentally to an immune system challenge had a 
greater increase in depressed mood, compared to men, but that there were no 
differences in levels of TNF- α or IL-6 post-challenge, nor in the association between 
these pro-inflammatory markers and depressed mood between men and women 
(Moieni et al., 2015). It is possible that inflammation may serve as a more important 
mediator of the relationship between persistent pathogens such as CMV and mood 
disorders as individuals age via a process referred to as “inflammaging” (Baylis et al., 
2013; Gruver et al., 2007). A recent study failed to find evidence for a causal 
association, however, between CMV and age-related changes in inflammation over time 
(Bartlett et al., 2012), warranting further clarification of the importance of inflammation 
as a mediator of the pathway between CMV as well as other persistent pathogens and 
mood disorder onset across the lifecourse.  
 A few limitations in the present study must be considered. First, NHANES III is a 
cross-sectional study, thus there is temporal ambiguity between the exposures and 
outcomes of interest. Indeed, while detection of IgG antibodies in the serum of 
individuals is a marker of previous exposure to the pathogens examined, we could not 
ascertain timing of acquisition of infection or frequency of reactivation of persistent 
pathogens in relation to mood disorder onset among individuals in our study. Moreover, 
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psychological distress resulting from adverse mental health conditions may also 
contribute to subsequent declines in immune function (Dhabhar, 2014). It is estimated 
that among those 12-19 years of age, the prevalence of CMV and HSV-1 is 41.7% and 
44.4% (Schillinger et al., 2004; Staras et al., 2006), respectively and among those 15-19 
years of age, seroprevalence of H. pylori is 29.1% (Staat et al., 1996).  We carried out 
sensitivity analyses in which we excluded cases of depression and bipolar disorder I if 
symptom onset occurred before the age of 12 (N=43 and N=14, respectively) (data not 
available for dysthymia), finding that most effect estimates did not change by more than 
10%, nor change in statistical significance (see Supplemental Tables 1 and 2). Future 
prospective studies in which incidence of mood disorders is ascertained from individuals 
who are free of mood disorders at baseline are needed, however, to better establish a 
causal association between persistent pathogens and onset of mood disorders over 
time.   
 Another limitation to our study is that mood disorder assessment was not based 
upon the most recent DSM criteria nor allow for redefining mood disorder classifications 
under the more recent National Institute of Mental Health Research Domain Criteria 
framework. Findings from this study lend support, however, for the potential inclusion of 
infection with persistent pathogens in the cluster of factors considered relevant under 
this framework. Numerous studies have demonstrated strong associations between 
socioeconomic factors and seropositivity as well as immune response to persistent 
pathogens (Dowd and Aiello, 2009; Dowd et al., 2009) and moreover, socioeconomic 
disparities in mood disorder outcomes such as depression (Lorant et al., 2003). In our 
study, we relied upon adjustment for socioeconomic position (SEP) at the household 
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level (i.e., PIR) as our sample combined young adults living within households as well 
as heads of households and educational attainment was unlikely to be completed for 
many of the individuals in our sample, and there could be residual confounding due to 
lack of control for individual SEP. It is unlikely, however, that residual confounding by 
socioeconomic factors would fully explain the associations observed as we also 
adjusted for several other factors that are correlated with individual level SEP including 
race/ethnicity, smoking status and BMI (Pampel et al., 2010). Data on IgG antibody 
levels was also limited to CMV and only available among women. In addition, CMV OD 
values among women tested for CMV seropositivity were top-coded and thus were 
dichotomized based upon an arbitrary cut-off point that may not correspond to an 
elevated immune response to CMV that is clinically relevant for these outcomes. Last, 
high sensitivity CRP testing was not performed in NHANES III and levels of CRP below 
the limit of detection were not available. Nonetheless, this study is, to our knowledge, 
the largest sample of individuals assessed for mood disorders and tested for persistent 
pathogens as well as inflammation and the only population-based study we are aware 
of that has examined these relationships with bipolar disorder.  
5. Conclusions 
To our knowledge, this is the first study to examine the association between 
several persistent pathogens and mood disorder outcomes among a population-based 
sample of young- to middle-aged women and men in the general U.S. population. Our 
findings, suggest that there may be important gender differences in the associations 
between CMV and H. pylori and mood disorders and that such pathogens may exert 
effects on these conditions outside of inflammatory pathways. Further examination of 
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social, biological and/or behavioral factors that may explain differences in the effect of 
persistent pathogens on mood disorders between women and men over time are 
therefore warranted.  
 
Conflict of interest statement  
All authors declare that there is no conflict of interest. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
21 
 
 
 
 
 
Funding 
This research did not receive any specific grant from funding agencies in the public, 
commercial, or not-for-profit sectors. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
22 
 
 
 
 
 
References 
 
Aiello, A.E., Feinstein, L., Dowd, J.B., Pawelec, G., Derhovanessian, E., Galea, S., 
Uddin,  
M., Wildman, D.E., Simanek, A.M., 2016. Income and Markers of Immunological 
Cellular Aging. Psychosom Med 78, 657-666. 
Amsterdam, J.D., Hernz, W.J., 1993. Serum antibodies to herpes simplex virus types I  
and II in depressed patients. Biological psychiatry 34, 417-420. 
American Psychiatric Association. Diagnostic and Statistical Manual of Mental 
Disorders,  
3rd Edition. 1980. Washington, DC. 
Barbosa, I.G., Machado-Vieira, R., Soares, J.C., Teixeira, A.L., 2014. The immunology 
of  
bipolar disorder. Neuroimmunomodulation 21, 117-122. 
Bartlett, D.B., Firth, C.M., Phillips, A.C., Moss, P., Baylis, D., Syddall, H., Sayer, A.A.,  
Cooper, C., Lord, J.M., 2012. The age-related increase in low-grade systemic  
inflammation (Inflammaging) is not driven by cytomegalovirus infection. Aging 
Cell  
11, 912-915. 
Baylis, D., Bartlett, D.B., Patel, H.P., Roberts, H.C., 2013. Understanding how we age:  
insights into inflammaging. Longevity & healthspan 2, 1. 
  
23 
 
Bennett, J.M., Glaser, R., Malarkey, W.B., Beversdorf, D.Q., Peng, J., Kiecolt-Glaser,  
J.K., 2012. Inflammation and reactivation of latent herpesviruses in older adults.  
Brain, behavior, and immunity 26, 739-746. 
Budzyński, J., Kłopocka, M., 2014. Brain-gut axis in the pathogenesis of Helicobacter  
pylori infection. World Journal of Gastroenterology : WJG 20, 5212-5225. 
Chuang, C.H., Sheu, B.S., Yang, H.B., Lee, S.C., Kao, A.W., Cheng, H.C., Chang, 
W.L.,  
Yao, W.J., 2009. Gender difference of circulating ghrelin and leptin 
concentrations  
in chronic Helicobacter pylori infection. Helicobacter 14, 54-60. 
Coryell, W., Scheftner, W., Keller, M., Endicott, J., Maser, J., Klerman, G.L., 1993. The  
enduring psychosocial consequences of mania and depression. The American  
journal of psychiatry 150, 720-727. 
Dantzer, R., O'Connor, J.C., Freund, G.G., Johnson, R.W., Kelley, K.W., 2008. From  
inflammation to sickness and depression: when the immune system subjugates 
the brain. Nature reviews. Neuroscience 9, 46-56. 
Dantzer, R., O'Connor, J.C., Lawson, M.A., Kelley, K.W., 2011. Inflammation-associated  
depression: from serotonin to kynurenine. Psychoneuroendocrinology 36, 426-
436. 
Deans, E., 2017. Microbiome and mental health in the modern environment. Journal of  
Physiological Anthropology 36, 1. 
Derhovanessian, E., Larbi, A., Pawelec, G., 2009. Biomarkers of human  
  
24 
 
immunosenescence: impact of Cytomegalovirus infection. Current Opinion in 
Immunology 21, 440-445. 
Derry, H.M., Padin, A.C., Kuo, J.L., Hughes, S., Kiecolt-Glaser, J.K., 2015. Sex  
Differences in Depression: Does Inflammation Play a Role? Curr Psychiatry Rep 
17, 78. 
Devkota, S., Wang, Y., Musch, M., Leone, V., Fehlner-Peach, H., Nadimpalli, A.,  
Antonopoulos, D.A., Jabri, B., Chang, E.B., 2012. Dietary fat-induced taurocholic 
acid production promotes pathobiont and colitis in IL-10(−/−) mice. Nature 487, 
104-108. 
Dhabhar, F.S., 2014. Effects of stress on immune function: the good, the bad, and the  
beautiful. Immunologic research 58, 193-210. 
Di Leo, V., D'Inca, R., Bettini, M.B., Podswiadek, M., Punzi, L., Mastropaolo, G., 
Sturniolo,  
G.C., 2005. Effect of Helicobacter pylori and eradication therapy on 
gastrointestinal  
permeability. Implications for patients with seronegative spondyloarthritis. The 
Journal of rheumatology 32, 295-300. 
Diflorio, A., Jones, I., 2010. Is sex important? Gender differences in bipolar disorder.  
International review of psychiatry 22, 437-452. 
Dominianni, C., Sinha, R., Goedert, J.J., Pei, Z., Yang, L., Hayes, R.B., Ahn, J., 2015.  
Sex, body mass index, and dietary fiber intake influence the human gut 
microbiome. PloS one 10, e0124599. 
  
25 
 
Dowd, J.B., Aiello, A., 2009. Socioeconomic Differentials in Immune Response in the 
U.S.  
Epidemiology (Cambridge, Mass.) 20, 902-908. 
Dowd, J.B., Aiello, A.E., Alley, D.E., 2009. Socioeconomic Disparities in the  
Seroprevalence of Cytomegalovirus Infection in the U.S. Population: NHANES III.  
Epidemiology and infection 137, 58-65. 
Dowd, J.B., Bosch, J.A., Steptoe, A., Blackburn, E.H., Lin, J., Rees-Clayton, E., Aiello,  
A.E., 2013. Cytomegalovirus is associated with reduced telomerase activity in the  
Whitehall II cohort. Experimental gerontology 48, 385-390. 
Dowd, J.B., Haan, M.N., Blythe, L., Moore, K., Aiello, A.E., 2008. Socioeconomic  
Gradients in Immune Response to Latent Infection. American Journal of  
Epidemiology 167, 112-120. 
Duggal, N.A., Upton, J., Phillips, A.C., Hampson, P., Lord, J.M., 2014. Depressive  
symptoms post hip fracture in older adults are associated with phenotypic and  
functional alterations in T cells. Immunity & Ageing 11, 25. 
Everhart, J.E., Kruszon-Moran, D., Perez-Perez, G.I., Tralka, T.S., McQuillan, G., 2000.  
Seroprevalence and Ethnic Differences in Helicobacter pylori Infection among  
Adults in the United States. The Journal of Infectious Diseases 181, 1359-1363. 
Evrensel, A., Ceylan, M.E., 2015. The Gut-Brain Axis: The Missing Link in Depression.  
Clinical Psychopharmacology and Neuroscience 13, 239-244. 
Ford, D.E., Erlinger, T.P., 2004. Depression and c-reactive protein in us adults: Data 
from  
  
26 
 
the third national health and nutrition examination survey. Archives of Internal 
Medicine 164, 1010-1014. 
Forty, L., Ulanova, A., Jones, L., Jones, I., Gordon-Smith, K., Fraser, C., Farmer, A.,  
McGuffin, P., Lewis, C.M., Hosang, G.M., Rivera, M., Craddock, N., 2014.  
Comorbid medical illness in bipolar disorder. The British Journal of Psychiatry 
205,  
465. 
Gecici, O., Kuloglu, M., Atmaca, M., Tezcan, A.E., Tunckol, H., EmÜL, H.M., Ustundag,  
B., 2005. High serum leptin levels in depressive disorders with atypical features. 
Psychiatry and Clinical Neurosciences 59, 736-738. 
Glaser R, K.-G.J., 1994. Stress-associated immune modulation and its implications for  
reactivation of latent herpesviruses. . In: Glaser R, J.J. (Ed.), Human Herpesvirus 
Infections. Marcel Dekker, New York, NY, pp. 245-270. 
Gruver, A., Hudson, L., Sempowski, G., 2007. Immunosenescence of ageing. The 
Journal  
of pathology 211, 144-156. 
Gunter, E., Lewis, BG, Koncikowski, SM, 1996. Laboratory Procedures Used for the 
Third  
National Health and Nutrition Examination Survey (NHANES III), 1988-1994. 
United States Department of Health and Human Services, Public Health Service, 
Centers for Disease Control and Prevention, Atlanta, GA. 
Hamdani, N., Doukhan, R., Kurtlucan, O., Tamouza, R., Leboyer, M., 2013. Immunity,  
  
27 
 
inflammation, and bipolar disorder: diagnostic and therapeutic implications. Curr 
Psychiatry Rep 15, 387. 
Haro, C., Rangel-Zúñiga, O.A., Alcalá-Díaz, J.F., Gómez-Delgado, F., Pérez-Martínez,  
P., Delgado-Lista, J., Quintana-Navarro, G.M., Landa, B.B., Navas-Cortés, J.A., 
Tena-Sempere, M., Clemente, J.C., López-Miranda, J., Pérez-Jiménez, F., 
Camargo, A., 2016. Intestinal Microbiota Is Influenced by Gender and Body Mass 
Index. PloS one 11, e0154090. 
Hirschfeld, R.M.A.W., M.M., 2002. Risk factors for major depression and bipolar 
disorder.  
In: Davis, K.L., Charney, D., Coyle, J.T., Nemeroff, C. (Ed.), 
Neuropsychopharmacology: The Fifth Generation of Progress. Lippincott, 
Williams, & Wilkins, Philadelphia, PA, pp. 1017-1024. 
Jaremka, L.M., Fagundes, C.P., Glaser, R., Bennett, J.M., Malarkey, W.B., Kiecolt- 
Glaser, J.K., 2013. Loneliness predicts pain, depression, and fatigue:  
understanding the role of immune dysregulation. Psychoneuroendocrinology 38, 
1310-1317. 
Kang, H.-J., Kim, S.-Y., Bae, K.-Y., Kim, S.-W., Shin, I.-S., Yoon, J.-S., Kim, J.-M., 
2015.  
Comorbidity of Depression with Physical Disorders: Research and Clinical 
Implications. Chonnam Medical Journal 51, 8-18. 
Kessler, R.C., Berglund, P., Demler, O., Jin, R., Merikangas, K.R., Walters, E.E., 2005.  
  
28 
 
Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the 
National Comorbidity Survey Replication. Archives of general psychiatry 62, 593-
602. 
Lee, F.K., Pereira, L., Griffin, C., Reid, E., Nahmias, A., 1986. A novel glycoprotein for  
detection of herpes simplex virus type 1-specific antibodies. Journal of virological 
methods 14, 111-118. 
Lorant, V., Deliege, D., Eaton, W., Robert, A., Philippot, P., Ansseau, M., 2003.  
Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol 157,  
98-112. 
Machado-Vieira, R., Ibrahim, L., Henter, I.D., Zarate, C.A., 2012. Novel glutamatergic  
agents for major depressive disorder and bipolar disorder. Pharmacology, 
Biochemistry, and Behavior 100, 678-687. 
Mathers, C.F., D.M.; Boerma, J.T., 2008. The global burden of disease: 2004 update.  
World Health Organization, Geneva, Switzerland. 
McCusker, R.H., Kelley, K.W., 2013. Immune-neural connections: how the immune  
system's response to infectious agents influences behavior. J Exp Biol 216, 84-
98. 
Mehta, S., Mittal, P.K., Swami, M.K., 2014. Psychosocial Functioning in Depressive  
Patients: A Comparative Study between Major Depressive Disorder and Bipolar 
Affective Disorder. Depression research and treatment 2014, 302741. 
Miller, A.H., 2010. Depression and Immunity: A Role for T cells? Brain, behavior, and  
immunity 24, 1-8. 
Miller, G.E., Freedland, K.E., Duntley, S., Carney, R.M., 2005. Relation of depressive  
  
29 
 
symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes 
simplex virus, Epstein-Barr virus) in patients with earlier acute coronary 
syndromes. The American journal of cardiology 95, 317-321. 
Moieni, M., Irwin, M.R., Jevtic, I., Olmstead, R., Breen, E.C., Eisenberger, N.I., 2015. 
Sex  
differences in depressive and socioemotional responses to an inflammatory 
challenge: implications for sex differences in depression. 
Neuropsychopharmacology 40, 1709-1716. 
Muneer, A., 2016. Bipolar Disorder: Role of Inflammation and the Development of  
Disease Biomarkers. Psychiatry investigation 13, 18-33. 
National Center for Health Statistics. Plan and Operation of the Third National Health 
and  
Nutrition Examination Survey, 1988–94. 2006. Centers for Disease Control,  
Hyattsville, MD. 
National Center for Health Statistics. Partial Household Adult Data File Documentation  
National Health and Nutrition Examination Survey, 1988–94. 2006. Centers for 
Disease Control and Prevention, Hyattsville, MD. 
Nazmi, A., Diez-Roux, A.V., Jenny, N.S., Tsai, M.Y., Szklo, M., Aiello, A.E., 2010. The  
influence of persistent pathogens on circulating levels of inflammatory markers: a 
cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis. BMC 
public health 10, 706. 
Ozsoy, S., Besirli, A., Abdulrezzak, U., Basturk, M., 2014. Serum Ghrelin and Leptin  
  
30 
 
Levels in Patients with Depression and the Effects of Treatment. Psychiatry 
investigation 11, 167-172. 
Pampel, F.C., Krueger, P.M., Denney, J.T., 2010. Socioeconomic Disparities in Health  
Behaviors. Annual review of sociology 36, 349-370. 
Phillips, A.C., Carroll, D., Khan, N., Moss, P., 2008. Cytomegalovirus is associated with  
depression and anxiety in older adults. Brain, behavior, and immunity 22, 52-55. 
Piccinelli, M., Wilkinson, G., 2000. Gender differences in depression. The British Journal  
of Psychiatry 177, 486. 
Prossin, A.R., Yolken, R.H., Kamali, M., Heitzeg, M.M., Kaplow, J.B., Coryell, W.H.,  
McInnis, M.G., 2015. Cytomegalovirus Antibody Elevation in Bipolar Disorder: 
Relation to Elevated Mood States. Neural plasticity 2015, 939780. 
Rector, J.L., Dowd, J.B., Loerbroks, A., Burns, V.E., Moss, P.A., Jarczok, M.N., Stalder,  
T., Hoffman, K., Fischer, J.E., Bosch, J.A., 2014. Consistent associations 
between measures of psychological stress and CMV antibody levels in a large 
occupational sample. Brain, behavior, and immunity 38, 133-141. 
Regier, D.A., Farmer, M.E., Rae, D.S., Locke, B.Z., Keith, S.J., Judd, L.L., Goodwin, 
F.K.,  
1990. Comorbidity of mental disorders with alcohol and other drug abuse. 
Results from the Epidemiologic Catchment Area (ECA) Study. Jama 264, 2511-
2518. 
Rhebergen, D., Beekman, A.T., de Graaf, R., Nolen, W.A., Spijker, J., Hoogendijk, W.J.,  
  
31 
 
Penninx, B.W., 2010. Trajectories of recovery of social and physical functioning 
in major depression, dysthymic disorder and double depression: a 3-year follow-
up. Journal of affective disorders 124, 148-156. 
Robinson, K., Argent, R.H., Atherton, J.C., 2007. The inflammatory and immune 
response  
to Helicobacter pylori infection. Best practice & research. Clinical 
gastroenterology 21, 237-259. 
Rolig, A.S., Cech, C., Ahler, E., Carter, J.E., Ottemann, K.M., 2013. The Degree of  
Helicobacter pylori-Triggered Inflammation Is Manipulated by Preinfection Host 
Microbiota. Infection and Immunity 81, 1382-1389. 
Ruggiero, P., 2010. Helicobacter pylori and inflammation. Current pharmaceutical 
design  
16, 4225-4236. 
Schillinger, J.A., Xu, F., Sternberg, M.R., Armstrong, G.L., Lee, F.K., Nahmias, A.J.,  
McQuillan, G.M., Louis, M.E., Markowitz, L.E., 2004. National seroprevalence 
and trends in herpes simplex virus type 1 in the United States, 1976-1994. 
Sexually transmitted diseases 31, 753-760. 
Simanek, A.M., Cheng, C., Yolken, R., Uddin, M., Galea, S., Aiello, A.E., 2014.  
Herpesviruses, inflammatory markers and incident depression in a longitudinal 
study of Detroit residents. Psychoneuroendocrinology 50, 139-148. 
Staat, M.A., Kruszon-Moran, D., McQuillan, G.M., Kaslow, R.A., 1996. A population- 
based serologic survey of Helicobacter pylori infection in children and 
adolescents in the United States. J Infect Dis 174, 1120-1123. 
  
32 
 
Staras, S.A., Dollard, S.C., Radford, K.W., Flanders, W.D., Pass, R.F., Cannon,  
M.J., 2006. Seroprevalence of cytomegalovirus infection in the United States, 
1988-1994. Clinical infectious diseases : an official publication of the Infectious 
Diseases Society of America 43, 1143-1151. 
Stec-Michalska, K., Malicki, S., Michalski, B., Peczek, L., Wisniewska-Jarosinska, M.,  
Nawrot, B., 2009. Gastric ghrelin in relation to gender, stomach topography and 
Helicobacter pylori in dyspeptic patients. World J Gastroenterol 15, 5409-5417. 
Toben, C., Baune, B.T., 2015. An Act of Balance Between Adaptive and Maladaptive  
Immunity in Depression: a Role for T Lymphocytes. J Neuroimmune Pharmacol 
10, 595-609. 
Trzonkowski, P., Mysliwska, J., Godlewska, B., Szmit, E., Lukaszuk, K., Wieckiewicz, J.,  
Brydak, L., Machala, M., Landowski, J., Mysliwski, A., 2004. Immune 
consequences of the spontaneous pro-inflammatory status in depressed elderly 
patients. Brain, behavior, and immunity 18, 135-148. 
Turner, J.E., Campbell, J.P., Edwards, K.M., Howarth, L.J., Pawelec, G., Aldred, S.,  
Moss, P., Drayson, M.T., Burns, V.E., Bosch, J.A., 2014. Rudimentary signs of 
immunosenescence in Cytomegalovirus-seropositive healthy young adults. Age 
36, 287-297. 
U.S. Department of Health and Human Services and U.S. Department of Agriculture.  
2015 – 2020 Dietary Guidelines for Americans. 8th Edition. December 2015. 
Available at http://health.gov/dietaryguidelines/2015/guidelines. 
Valkanova, V., Ebmeier, K.P., Allan, C.L., 2013. CRP, IL-6 and depression: a 
systematic  
  
33 
 
review and meta-analysis of longitudinal studies. Journal of affective disorders 
150, 736-744. 
van der Heiden, M., van Zelm, M.C., Bartol, S.J.W., de Rond, L.G.H., Berbers, G.A.M.,  
Boots, A.M.H., Buisman, A.-M., 2016. Differential effects of Cytomegalovirus 
carriage on the immune phenotype of middle-aged males and females. Scientific 
reports 6, 26892. 
Zarouna, S., Wozniak, G., Papachristou, A.I., 2015. Mood disorders: A potential link  
between ghrelin and leptin on human body? World Journal of Experimental 
Medicine 5, 103-109. 
Zhu, J., Shearer, G.M., Norman, J.E., Pinto, L.A., Marincola, F.M., Prasad, A., 
Waclawiw,  
M.A., Csako, G., Quyyumi, A.A., Epstein, S.E., 2000. Host Response to 
Cytomegalovirus Infection as a Determinant of Susceptibility to Coronary Artery 
Disease. Circulation 102,  
2491. 
 
 
 
 
  
34 
 
  
-0.5
-0.25
0
0.25
0.5
0.75
1
1.25
1.5
1.75
2
2.25
2.5
2.75
O
d
d
s
 
R
a
t
i
o
 
a
n
d
 
9
5
%
 
C
o
n
f
i
d
e
n
c
e
 
I
n
t
e
r
v
a
l
 
f
o
r
 
E
l
e
v
a
t
e
d
 
C
R
P
 
L
e
v
e
l
 
(
≥
0
.
3
 
m
g
/
d
L
)
Figure 1. Association Between Persistent Pathogens and C-reactive Protein Level 
Among U.S. Adults 15-39 Years of Age in the National Health and Nutrition Examination 
Survey III (1988-1994)
CMV                                        HSV-1                                    H. pylori                      CMV 
IgG 
Level
Overall    Women      Men       Overall    Women      Men      Overall    Women       Men      Women   
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Table 1 Legend 
CMV; cytomegalovirus, DSM-III; Diagnostic and Statistical Manual of Mental Disorders, 3rd Edition, HSV-1; herpes 
simplex virus-1, H. pylori; Helicobacter pylori, IgG; Immunoglobulin G, NSAID; non-steroidal anti-inflammatory drug.  
aN=7230 for overall sample, N=3927 for women, N=3303 for men. 
bN=7227 for overall sample, N=3918 for women, N=3309 for men. 
cN=7251 for overall sample, N=3983 for women, N=3304 for men. 
dN=6886 for overall sample, N=3747 among women, and N=3139 among men. 
eIgG antibody levels among CMV seropositive women only. 
fN=6828 for overall sample, N=2981 for women, and N=2683 for men. 
gN=3185 for overall sample, N=1634 for women, and N=1551 for men. 
hN=7345 for overall sample, N=3721 for women, and N=3107 for men. 
iN=7294 for overall sample, N=3966 for women, and N=3325 for men. 
jN=7292 for overall sample, N=3967 for women, and N=3325 for men. 
*P<0.05. 
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 Table 2 Legend 
CMV; cytomegalovirus, IgG; immunoglobulin G, HSV-1; herpes simplex virus-1, H. pylori; 
Helicobacter pylori 
aModels adjusted for age, gender, race/ethnicity, poverty income ratio, smoking status, 
alcohol use, body mass index (kg/m2) and use of mood disorder and/or infection-related 
medications. Models for C-reactive protein adjusted for age, gender, race/ethnicity, poverty 
income ratio, smoking status, alcohol use, body mass index (kg/m2) and use of mood 
disorder-related and/or non-steroidal anti-inflammatory medications. 
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bN=6813 for overall sample, N=3695 for women, and N=3118 for men. 
cN=2306 for CMV seropositive women. 
dN=5609 for overall sample, N=2945 for women, and N=2664 for men. 
eN=3160 for overall sample, N= 1621 for women, and N=1539 for men. 
fN=6776 for overall sample, N=3697 for women, and N=3097 for men. 
*P<0.05 
 
 
 
 
 
 
 
 
 
Table 3 Legend 
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CMV; cytomegalovirus, IgG; immunoglobulin G, HSV-1; herpes simplex virus-1, H. pylori; 
Helicobacter pylori 
aModels adjusted for age, gender, race/ethnicity, poverty income ratio, smoking status, 
alcohol use, body mass index (kg/m2) and use of mood disorder and/or infection-related 
medications. Models for C-reactive protein adjusted for age, gender, race/ethnicity, poverty 
income ratio, smoking status, alcohol use, body mass index (kg/m2) and use of mood 
disorder-related and/or non-steroidal anti-inflammatory medications. 
bN=6778 for overall sample, N=3696 for women, and N=3082 for men. 
cN=2358 for CMV seropositive women. 
dN=5618 for overall sample, N=2974 for women, and N=2671 for men. 
eN=3167 for overall sample, 1621 for women, and N=1546 for men. 
fN=6788 for overall sample, N=3702 for women, and N=3086 for men. 
*P<0.05 
**P<0.06 
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Table 4 Legend 
CMV; cytomegalovirus, IgG; immunoglobulin G, HSV-1; herpes simplex virus-1, H. pylori; 
Helicobacter pylori 
aModels for pathogens adjusted for age, gender, race/ethnicity, poverty income ratio, 
smoking status, alcohol use, body mass index (kg/m2) and use of mood disorder and/or 
infection-related medications. Models for C-reactive protein adjusted for age, gender, 
race/ethnicity, poverty income ratio, smoking status, alcohol use, body mass index (kg/m2) 
and use of mood disorder-related and/or non-steroidal anti-inflammatory medications. 
bN=6823 for overall sample, N=3698 for women, and N=3125 for men. 
cN=2358 for CMV seropositive women. 
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dN=5617 for overall sample, N=2946 for women, and N=2671 for men. 
eN=3167 for overall sample, 1621 for women, and N=1546 for men. 
eN=3167 for overall sample, 1621 for women, and N=1546 for men. 
fN=6786 for overall sample, N=3700 for women, and N=3086 for men. 
*P<0.05 
 
 
 
 
 
 
 
 
Figure 1 Legend 
CMV; cytomegalovirus, IgG; immunoglobulin G, HSV-1; herpes simplex virus-1, H. pylori; 
Helicobacter pylori 
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aModels adjusted for age, gender, race/ethnicity, poverty income ratio, smoking status, 
alcohol use, body mass index (kg/m2) and use of infection-related and/or non-steroidal anti-
inflammatory medications. 
bN=6778 for overall sample, N=3696 for women, and N=3082 for men. 
dN=5623 for overall sample, N=2960 for women, and N=2663 for men. 
eN=3159 for overall sample, N=1624 for women, and N=1535 for men. 
cN=2312 for CMV seropositive women. 
*P<0.05 
 
Table 1. Population weighted socioedemographic and behavioral characteristics of individuals 15-39 years of age 
assessed for mood disorders via DSM-III criteria in the National Health and Nutrition Examination Survey III (1988-
1994) 
 
Characteristics 
Total Population 
(N=7294) 
Women (N=3969) Men (N=3325) P-value 
Age, years (mean ± SE) 27.6 ± 0.17 27.7 ± 0.24 27.6 ± 0.19 0.8836 
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Gender, N (%)  
    
     Female 3969 (50.8) --- --- ---- 
     Male 3325 (49.2) --- ---  
Race/Ethnicity, N (%)  
    
     Non-Hispanic White 2277 (78.9) 1287 (78.5) 990 (79.3)   0.0007* 
     Non-Hispanic Black 2558 (13.9) 1426 (14.8) 1132 (12.9)  
     Mexican-American              2459 (7.2) 1256 (6.7) 1203 (7.8)  
Poverty Income Ratio, N (%) 
    
      0-125% 2744 (20.5) 1264 (22.4) 1177 (18.5)    0.0011* 
      >125-249% 2167 (27.6) 1138 (27.8) 1029 (27.5)  
      > 250% 2383 (51.9) 1567 (49.8) 1119 (54.0)  
Smoking Status  
    
     Never 4446 (53.3) 2625 (56.4) 1821 (50.1)    0.0012* 
     Former 812 (13.6) 379 (12.4) 433 (14.8)  
     Current 2036 (33.1) 965 (31.2) 1071 (35.0)  
Alcohol Use, N (%) 
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     Never 3530 (38.1) 2434 (48.0) 1096 (27.8)    <0.0001* 
     Moderate 2443 (42.6) 1111 (39.6) 1332 (45.7)  
     Heavy 1321 (19.4) 424 (12.4) 987 (26.5)  
Body mass index (kg/m2) (mean ± SE) 25.2 ± 0.13 25.0 ± 0.18 25.5 ± 0.15 0.0458* 
Mood Disorder-related Drug Use a, N (%) 
    
  
    
      No 7125 (98.4) 3857 (97.8) 3268 (99.1)   0.0075* 
 
    
      Yes 105 (1.6) 70 (2.2) 35 (0.9)  
 
    
Infection-related Drug Use b, N (%)b 
    
 
    
     No 6691 (91.3) 3547 (88.3) 3144 (94.4)   <0.0001* 
 
    
     Yes 536 (8.7) 371 (11.7) 165 (5.6)  
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NSAID Usec, N (%) 
    
 
    
     No 5424 (69.1) 2710 (61.5) 2714 (77.0)  <0.0001* 
 
    
     Yes 1827 (30.9) 1273 (38.5) 590 (23.0)  
 
    
CMV Serostatusd, N (%)  
    
     Seronegative 2446 (53.5) 1144 (47.0) 1302 (60.0)   <0.0001* 
     Seropositive 4440 (46.5) 2603 (53.0) 1837 (40.0)  
CMV IgG Antibody Levele 
    
    Low (≤ 3.0 OD units)  1282 (56.8)  ---- 
     
    High (>3.0 OD units)  1054 (43.2)   
     
HSV-1 Serostatusf, N (%)  
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     Seronegative 1695 (42.0) 829 (38.8) 866 (45.3)  0.0299* 
     Seropositive 3969 (58.0) 2152 (61.2) 1817 (54.7)  
H. pylori serostatusg, N (%) 
    
     
     Seronegative 1941 (77.0) 1041 (78.7) 900 (75.2)  0.1457 
     
     Seropositive 1244 (23.0) 593 (21.3) 651 (24.8)  
     
C-reactive Protein Levelh 
    
     
     
     Low (< 0.3 mg/dL) 5162 (79.9) 2564 (73.7) 2598 (86.4) <0.0001* 
     
     High (≥ 0.3 mg/dL) 1666 (20.1) 1157 (26.3) 509 (13.6)  
     
Major Depressioni 
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     No 6753 (92.0) 3585 (89.1) 3168 (94.9) <0.0001* 
     
     Yes 528 (8.0) 379 (10.9) 149 (5.1)  
     
Dysthymia 
    
     
    No 6764 (94.0) 3613 (92.3) 3151 (95.8) <0.0001* 
     
    Yes 530 (6.0) 356 (7.7) 174 (4.2)  
     
Bipolar Disorder Ij 
    
    0.8068 
    No 7222 (99.2) 3927 (99.2) 3295 (99.2)  
     
    Yes 70 (0.8) 40 (0.8) 30 (0.8)  
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Table 2. Association Between Persistent Pathogens, C-reactive protein and Lifetime History of 
Major Depression Among U.S. Adults 15-39 Years of Age in the National Health and Nutrition 
Examination Survey III (1988-1994) 
 
Odds Ratio (95% Confidence Interval)a  
 
Total Population Women Men P-value 
Pathogens 
    
CMV Serostatusb 
    
     Seronegative 1.0 1.0 1.0  
     Seropositive 0.86 (0.64, 1.16) 1.09 (0.74, 1.58) 0.54 (0.32, 0.91)* 0.0405* 
CMV IgG Antibody Levelc 
    
      Low (≤ 3.0 OD units) -- 1.0 --  
      High (> 3.0 OD units) -- 1.25 (0.78, 2.04) --  
HSV-1 Serostatusd 
   0.2520 
     Seronegative 1.0 1.0 1.0  
     Seropositive 0.85 (0.61, 1.20) 0.97 (0.64, 1.48) 0.67 (0.41, 1.10)  
H. pylori Serostatuse 
   0.0037* 
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     Seronegative 1.0 1.0 1.0  
     Seropositive 0.98 (0.46, 2.10) 1.76 (0.73, 4.28) 0.29 (0.13, 0.62)*  
C-reactive protein levelf 
    
     Low (< 0.3 mg/dL) 1.0 1.0 1.0 0.0001* 
     High (≥ 0.3 mg/dL) 1.17 (0.79, 1.75) 0.70 (0.46, 1.08) 2.97 (1.56, 5.64)*  
  
 
 
 
 
Table 3. Association Between Persistent Pathogens, C-reactive protein and Lifetime History of Dysthymia 
Among U.S. Adults 15-39 Years of Age in the National Health and Nutrition Examination Survey III (1988-
1994) 
 
Odds Ratio (95% Confidence Interval)a  
 
Total Population Women Men p-value 
Pathogens 
    
CMV Serostatusb 
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     Seronegative 1.0 1.0 1.0 0.5927 
     Seropositive 0.99 (0.70, 1.40) 1.21 (0.75, 1.69) 0.87 (0.46, 1.65)  
CMV IgG Antibody Levelc 
    
      Low -- 1.0 -- ---- 
      High -- 1.50 (0.93, 2.41)** --  
HSV-1 Serostatusd 
    
     Seronegative 1.0 1.0 1.0 0.3468 
     Seropositive 1.06 (0.74, 1.51) 0.90 (0.57, 1.46) 1.47 (0.76, 2.86)  
H. pylori Serostatuse 
    
     Seronegative 1.0 1.0 1.0 0.0075* 
     Seropositive 1.38 (0.65, 2.91) 2.47 (1.06, 5.73)* 0.51 (0.28, 0.92)*  
C-reactive protein levelf 
    
     Low (< 0.3 mg/dL) 1.0 1.0 1.0 0.0023* 
     High (≥ 0.3 mg/dL) 1.40 (0.89, 2.20) 0.92 (0.56, 1.50) 2.87 (1.56, 5.28)*  
 
Table 4. Association Between Persistent Pathogens and Lifetime History of Bipolar Disorder I Among U.S. 
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Adults 15-39 Years of Age in the National Health and Nutrition Examination Survey III (1988-1994) 
 
Odds Ratio (95% Confidence Interval)a  
 
Total Population Women Men P-value 
Pathogens 
    
CMV Serostatusb 
    
     Seronegative 1.0 1.0 1.0 0.1620 
     Seropositive 0.75 (0.31, 1.81) 1.43 (0.48, 4.26) 0.37 (0.07, 2.05)  
CMV IgG Antibody Levelc 
    
      Low -- 1.0 -- ---- 
      High --   4.34 (0.92, 20.45)** --  
HSV-1 Serostatusd 
    
     Seronegative 1.0 1.0 1.0 0.5167 
     Seropositive 0.99 (0.47, 2.08) 1.31 (0.35, 4.86) 0.84 (0.31, 2.25)  
H. pylori Serostatuse 
    
     Seronegative 1.0 1.0 1.0 0.1556 
     Seropositive 0.64 (0.20, 2.10) 0.89 (0.35, 2.27) 0.24 (0.06, 0.91)*  
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C-reactive protein levelf 
    
     Low (< 0.3 mg/dL) 1.0 1.0 1.0 0.3161 
     High (≥ 0.3 mg/dL) 2.13 (0.81, 5.64) 1.14 (0.34, 3.79) 3.29 (0.80, 13.53)  
 
 
